In just a few short months, COVID-19 has impacted how we work, communicate with others and go about our daily lives. The pharmaceutical industry has reacted quickly, changing the ways their teams engage with customers, reducing face-to-face interactions and increasing the use of digital and remote channels.
We asked senior leaders across the industry about the impact COVID-19 has had on their businesses, and how their customer-engagement strategies could change as a result. Our new report collates these responses and provides a snapshot of how the industry aims to adapt over the next few years as it continues to offer valuable interactions.
Follow this link to download the report, and we’ll also send you a copy of our brand new in-depth whitepaper: Reimagining HCP engagement, which looks at recent HCP research and draws upon the experience of our colleagues to reimagine what omnichannel engagement will look like as we enter a whole ‘new normal’.
Follow this link to download your copy of our report and whitepaper.